Press Releases

Special Edition 13: Predictmedix Brings AI to Canadian Retail Including COVID-19 Screening

May 27, 2020 - Media

An off-schedule podcast discussion with Dr. Rahul Kushwah, the co-founder and Chief Operating Officer at PredictMedix Inc, an artificial intelligence (AI) company with technology that tests for symptoms of COVID-19 and can be used to monitor spaces. Dr. Kushwah discusses how PredictMedix AI can screen for COVID-19 and physical distance enforcement in stores, malls, and […]

PredictMedix signs large North American contract with Juiceworks Exhibits

May 20, 2020 - Media

PredictMedix (CSE: PMED- OTCQB: PMEDF) CEO Rahul Kushwah joined Steve Darling from Proactive Vancouver to share news the company has agreed to terms on a deal with Juiceworks Exhibits. Juiceworks is a North American company that custom-designs exhibits and event experiences. Dr Kushwah discusses how big this deal is for the company and also how […]

Predictmedix Inc. Announces a Major North American Sales Contract With Juiceworks Exhibits

May 20, 2020 - Press Releases

Predictmedix Inc. Announces a Major North American Sales Contract with Juiceworks Exhibits for its COVID-19 Mass Screening Technology TORONTO, ON / ACCESSWIRE / May 20, 2020 / Predictmedix Inc. (PMED.CN) (PMEDF) (“Predictmedix” or the “Company”) is pleased to announce the execution of a sales contract for its COVID-19 screening technology with Juiceworks Exhibits (“Juiceworks”), a […]

PredictMedix: Pharma Monopoly Meets Tech Growth

May 15, 2020 - Media

Here’s a simple and effective investment strategy: invest in companies that sell products with growing inelastic demand. Let’s unpack what that means. The price elasticity of demand for a product is the degree of responsiveness to which the demand for a product changes with respect to price. If the total demand falls/rises 20% for a […]

PredictMedix Adds Microsoft AI Veteran to Chair of Company’s Advisory Board

May 12, 2020 - Media

PredictMedix (CSE:PMED-OTCQB: PMEDF) CEO Dr Rahul Kushwah and Director of business development and AI absolutions for Microsoft, Kapil Raval joined Steve Darling from Proactive Vancouver with news Mr Raval has been named as Chair of the PredictMedix’s advisory board. Dr Kushwah telling Proactive why they chose Mr Raval to head that board and Raval gives […]

Predictmedix Inc. Announces Appointment of Microsoft Director of Business Development

May 12, 2020 - Press Releases

Predictmedix Inc. Announces Appointment of Microsoft Director of Business Development for AI Solutions as the Chairman of the Advisory Board  Predictmedix Bolsters its Advisory Board with Key Technology Director Kapil Raval TORONTO, ON / ACCESSWIRE / May 12, 2020 / Predictmedix Inc. (CSE:PMED) (OTCQB:PMEDF) (“Predictmedix” or the “Company”) is pleased to announce the appointment of […]

Predictmedix Inc. Announces Deployment of its Mass Screening Technology for Covid-19 With Max Healthcare

May 6, 2020 - Press Releases

Predictmedix launches its COVID-19 screening technology in healthcare TORONTO, ON / ACCESSWIRE / May 6, 2020 / Predictmedix Inc. (CSE:PMED)(OTCQB:PMEDF) (“Predictmedix” or the “Company”) is pleased to announce that the company has begun deployment of its artificial intelligence (“AI”) technology for mass screening of COVID-19 with Max Healthcare. Max Healthcare is one of the largest […]

Predictmedix Submits Patent Application for Mass Screening for Infectious Diseases

Apr 27, 2020 - Media

Predictmedix (CSE: PMED-OTCQB: PMEDF) CEO Dr Rahul Kushwah joined Steve Darling from Proactive to bring news the company has filed a patent for their game-changing technology for mass screening for infectious disease such as COVID-19. Dr Kushwah discusses how the technology works and why he feels airports, stadiums and other large venues could be a […]

Predictmedix Inc. Files Patent for Mass Screening for Infectious Diseases

Apr 27, 2020 - Press Releases

TORONTO, April 27, 2020 /CNW/ – Predictmedix Inc. (CSE: PMED) (OTCQB: PMEDF) (“Predictmedix” or the “Company”) is pleased to announce that it has filed Patent Application Number 63012510 – Artificial Intelligence driven rapid screening system for infectious diseases, such as SARS-CoV-2 virus responsible for COVID-19, with the United States Patent and Trademark Office. COVID-19 and […]

Clinical Experts Join Predictmedix Inc. to Advise Development of Covid-19 Screening Technology

Apr 14, 2020 - Press Releases

April 14, 2020 (Source) – Predictmedix Inc. (CNSX:PMED) (OTC:PMEDF) (formerly Cultivar Holdings Inc.) (the “Company”) has signed exclusive advisory agreements with clinicians in emergency and pulmonary medicine to aid its efforts in delivering artificial intelligence (“AI”) powered technologies for COVID-19 screening. Predictmedix Inc. is welcoming to their advisory board high profile clinical experts who are dealing […]

CSE Bulletin: Name and Symbol Change – Cultivar Holdings Inc. (CULT)

Apr 8, 2020 - Press Releases

Toronto, Ontario–(Newsfile Corp. – Le 8 avril/April 2020) – Cultivar Holdings Inc. has announced a name and symbol change to Predictmedix Inc. (PMED). Shares will begin trading under the new name and symbol on April 9, 2020. Disclosure documents are available at www.thecse.com Please note that all open orders will be cancelled at the end […]